Inventor

GUREWICH VICTOR

US11 patents

⚠️ This page may combine multiple inventors who share the name “GUREWICH VICTOR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THROMBOLYTIC SCIENCE LLC

3 patents

US12590301B2Mar 31, 2026

Methods for safe and effective thrombolysis using sequential administration of tissue plasminogen activator and mutant pro-urokinase

THROMBOLYTIC SCIENCE LLC0 citations59

US11213574B2Jan 4, 2022

Methods for safe and effective thrombolysis using sequential administration of tissue plasminogen activator and mutant pro-urokinase

THROMBOLYTIC SCIENCE LLC1 citations59

US11154596B2Oct 26, 2021

Methods for thrombolysis

THROMBOLYTIC SCIENCE LLC0 citations59

NEW ENGLAND DEACONESS HOSPITAL

2 patents

US5759542AJun 2, 1998

Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases

NEW ENGLAND DEACONESS HOSPITAL532 citations98

US5472692ADec 5, 1995

Pro-urokinase mutants

NEW ENGLAND DEACONESS HOSPITAL52 citations93

(unassigned)

1 patent

US5626841AMay 6, 1997

Use of intra-platelet urokinase-type plasminogen activators for long-term inhibition of thrombosis

24 citations91

HUASIN SYED S

1 patent

US4381346AApr 26, 1983

Isolation of plasminogen activators useful as therapeutic and diagnostic agents

HUASIN SYED S31 citations82

BETH ISRAEL HOSPITAL

1 patent

US7837992B2Nov 23, 2010

C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis

BETH ISRAEL HOSPITAL12 citations81

THROMBOLYTIC SCIENCE INC

1 patent

US7074401B2Jul 11, 2006

Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots

THROMBOLYTIC SCIENCE INC11 citations79

GUREWICH VICTOR

1 patent

US8187592B2May 29, 2012

C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis

GUREWICH VICTOR5 citations66

FFE THERAPEUTICS LLC

1 patent

US10081673B2Sep 25, 2018

Compositions and methods for treating angiogenesis-related disorders

FFE THERAPEUTICS LLC0 citations44